Pharmaceutical preparations for the treatment of X-linked hypophosphatemia; pharmaceutical preparations for the treatment of tumor-induced osteomalacia; pharmaceutical preparations for the treatment of pediatric rickets; pharmaceutical preparations comprising an anti-FGF23 (fibroblast growth factor 23) monoclonal antibody